2004 Proteoglycan

2004年蛋白多糖

• 批准号: 6837895
• 负责人: ANNA H. PLAAS
• 金额: $ 3.1万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-06-01 至 2004-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6837895
• 关键词: meeting /conference /symposium; molecular genetics; protein metabolism; protein structure function; proteoglycan; travel

DESCRIPTION (provided by applicant): The 11th Gordon Conference on Proteoglycans (PGs) will be held July 11th-16th, 2004 at the Proctor Academy, Andover, ! New Hampshire. We plan to provide a forum for high quality presentation and in-depth discussion of the most recent research discoveries in the structure, function, genetics, metabolic regulation and clinical applications of PGs. We also aim to continue the important role that this conference has played over the past 20 years in maintaining the cohesiveness and growth of this research community. This group now includes worldwide investigators from cell biological, biochemical, engineering and clinical backgrounds in academic, government and corporate laboratories. The following major themes will be covered in the program: 1) Molecular Mechanisms of PG Metabolism; 2) Role of PGs in Regulating Cellular Dynamics; 3) PGs in Malignancy and Inflammation; 4) PGs in Developmental Biology and Regenerative Medicine; 5) Structural PG Biology; 6) Emergence of Glycan Therapies. We have planned eight sessions with a total of 30 plenary talks, and each session will be chaired by a known expert in the field. The program will provide opportunity for participation of investigators at all levels and also those currently funded through the NIH, including, NIAMS, NCI, NINDS, NIHLBI, NIA, NIDDK and NCCAM. About 35% of the planned presentations will report novel data on the role of PGs in cartilage and bone or skin health and disease; the remaining talks will cover PGs in the cell biology of cancer initiation and progression, PGs in CNS development and in progression of neurological disease, such as stroke, Alzheimer's and spinal cord injuries, PGs in heart, lung and blood vessel diseases and potential usage of PGs in tissue engineering. The program format will also provide opportunity for 20 "short-talk" presentations. These will be selected by the individual session chairs from submitted abstracts. About 100 posters will be displayed, thematically split into 2 sessions, and an online interactive molecular modeling station will be available in the posteI display area. The final list of 150 conferees (session chairs, speaker and participants) will assure a balanced representation of researchers from all sectors. We will particularly promote the participation of junior investigators, post-doctoral trainees and 'new investigators to the field', in all aspects of the meeting, as we see their representation as [critical for the development of new technical approaches and the initiation of PG-related research into yet unexplored Ibiological systems and diseases. Furthermore, throughout the conference program we will foster the involvement of women, diverse groups of minorities and handicapped individuals who are planning to enter into protoeoglycan research.

描述(由申请人提供)： 第11届戈登蛋白多糖(PGs)会议将于2004年7月11日至16日在安多弗的普罗科特学院举行！新汉普郡。我们计划提供一个论坛，高质量地介绍和深入讨论在PG的结构、功能、遗传学、代谢调节和临床应用方面的最新研究发现。我们还致力于继续发挥这次会议在过去20年中在维持这个研究界的凝聚力和发展方面所发挥的重要作用。该小组现在包括来自学术、政府和企业实验室的细胞生物、生化、工程和临床背景的世界各地的研究人员。该计划将涵盖以下主要主题：1)PG代谢的分子机制；2)PG在调节细胞动力学中的作用；3)PG在恶性肿瘤和炎症中的作用；4)PG在发育生物学和再生医学中的作用；5)结构PG生物学；6)多糖疗法的出现。我们计划举行八次会议，共举行30次全体会谈，每届会议将由该领域的一名知名专家主持。该计划将为所有级别的调查人员以及目前由NIH资助的调查人员提供机会，包括NIAMS、NCI、NINDS、NIHLBI、NIA、NIDDK和NCCAM。在计划中的演讲中，约有35%将报道有关前列腺素在软骨、骨骼或皮肤健康和疾病中的作用的新数据；其余的演讲将涉及前列腺素在癌症发生和进展的细胞生物学中的作用，前列腺素在中枢神经系统发育和神经疾病进展中的作用，如中风、阿尔茨海默氏症和脊髓损伤，前列腺素在心、肺和血管疾病中的潜在用途，以及前列腺素在组织工程中的潜在用途。节目形式还将提供20个短谈演讲的机会。这些将由各届会议主席从提交的摘要中选出。大约100张海报将被展示，按主题分为两个部分，在POSTEI展示区将提供一个在线互动分子模型站。150名与会者(会议主席、发言者和与会者)的最终名单将确保来自所有部门的研究人员的均衡代表。我们将特别促进初级研究人员、博士后实习生和“实地新调查人员”参与会议的各个方面，因为我们认为他们的代表[对于开发新的技术方法和启动与PG相关的研究尚未探索的生物系统和疾病至关重要]。此外，在整个会议计划中，我们将促进妇女、不同的少数群体和残疾个人的参与，他们计划进入原多糖研究。